Innealta Capital’s Twist Bioscience TWST Stock Holding History

Innealta Capital’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-52	Closed	-$2.56K	–	1576
2024 Q2	$2.56K	Buy	+52	New	+$2.12K	﹤0.01%	1018

Other funds holding TWST

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Innealta Capital's TWST Position: Q3 2024 in Review

Innealta Capital sold out of Twist Bioscience (TWST) in Q3 2024, closing a stake of 52 shares — an estimated $2.56K sold.

Innealta Capital first reported a position in TWST in Q2 2024 and held it in 1 quarter. The position peaked at $2.56K in Q2 2024. 245 funds tracked by Wall St. Rank hold TWST as of Q3 2024.

Innealta Capital reported no remaining Twist Bioscience position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 52 Twist Bioscience shares in Q3 2024, an estimated $2.56K.
Innealta Capital first reported a position in Twist Bioscience in Q2 2024 and held it in 1 quarter.
Innealta Capital's Twist Bioscience position peaked at $2.56K in Q2 2024.
245 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.